Table 4.
Willing to inject and pay for vaccine characteristics of respondents
| Characteristics | n | % |
|---|---|---|
| Willingness to injection |
|
|
|
Will not vaccinate
|
13 |
1.5 |
|
Not decided yet, waiting for more information
|
111 |
13.2 |
|
Will vaccine once vaccine becomes officially approved
|
551 |
65.4 |
|
Ready to vaccinate in the vaccine trial
|
167 |
19.8 |
| Reasons for vaccine hesitancy |
|
|
|
Insufficient information about monkeypox
|
296 |
41.2 |
|
Not feeling well
|
61 |
8.5 |
|
Having underlying diseases / comorbidities
|
27 |
3.8 |
|
Allergic
|
42 |
5.9 |
|
Insufficient information about vaccine’s side effects
|
234 |
32.6 |
|
Not decided, waiting for more information
|
58 |
8.1 |
|
Cannot access health institutions to vaccinate
|
22 |
3.1 |
|
Still suffering from side effects of last vaccination
|
30 |
4.2 |
|
Feeling vaccination is unnecessary
|
26 |
3.6 |
| Willing to pay |
|
|
|
Unwilling to pay
|
162 |
19.2 |
|
20% of cost
|
124 |
14.7 |
|
50% of cost
|
258 |
30.6 |
|
80% of cost
|
122 |
14.5 |
|
Full cost
|
176 |
20.9 |
| Economic burden |
|
|
|
No
|
302 |
36.6 |
| Yes | 522 | 63.4 |